Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease
Journal of Molecular Recognition · 2024-11 · 37 (6)
DOI: 10.1002/jmr.3101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Recognition, online erschienen am 02.09.2024. Verfasst von Wenjin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Indoles, Coronavirus 3C Proteases, SARS-CoV-2, Molecular Docking Simulation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The SARS‐CoV‐2 main protease (Mpro) is an essential enzyme that promotes viral transcription and replication. Mpro conserved nature in different variants and its nonoverlapping nature with human proteases make it an attractive target for therapeutic intervention against SARS‐CoV‐2. In this work, the interaction mechanism between Mpro and diindolylmethane derivatives was investigated by molecular docking, enzymatic inhibition assay, UV–vis, fluorescence spectroscopy, and circular dichroism spectroscopy. Results of IC 50 values show that 1p (9.87 μM) was the strongest inhibitor for Mpro in this work, which significantly inhibited the activity of Mpro. The binding constant (4.07 × 10 5 Lmol −1 ), the quenching constant (5.41 × 10 5 Lmol −1 ), and thermodynamic parameters indicated that the quenching mode of 1p was static quenching, and the main driving forces between 1p and Mpro are hydrogen bond and van der Waals force. The influence of molecular structure on the binding is investigated. Chlorine atoms and methoxy groups are favorable for the diindolylmethane derivative inhibitors of Mpro. This work confirms the changes in the microenvironment of Mpro by 1p , and provides clues for the design of potential inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China.
- College of Pharmacy, Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Ruiyong Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, W., Chang, X., Zhou, H., Yu, W., Wang, R., & Chang, J. (2024). Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease. Journal of Molecular Recognition, 37(6). https://doi.org/10.1002/jmr.3101
Vancouver
Li W, Chang X, Zhou H, Yu W, Wang R, Chang J. Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease. Journal of Molecular Recognition. 2024;37(6). doi:10.1002/jmr.3101
BibTeX
@article{Li2024,
author = {Li, Wenjin and Chang, Xiaoyu and Zhou, Hang and Yu, Wenquan and Wang, Ruiyong and Chang, Junbiao},
title = {Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease},
journal = {Journal of Molecular Recognition},
year = {2024},
volume = {37},
number = {6},
doi = {10.1002/jmr.3101}
}
EUVIMED